Cardiovascular Disease (CVD) Completed Phase 3 Trials for Raloxifene (DB00481)

Also known as: Cardiovascular Heart Disease / Cardiovascular Disease (CKD) / Cardiovascular (CV) Disease / Cardiovascular Disease / Cardiovascular Diseases

IndicationStatusPhase
DBCOND0057913 (Cardiovascular Disease (CVD))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00190593Raloxifene Use for The HeartPrevention